Inhibition of TRP channels as a treatment for cardiac hypertrophy and heart failure

Details for Australian Patent Application No. 2004291102 (hide)

Owner Board of Regents, The University of Texas System Myogen, Inc.

Inventors Olson, Eric; Bush, Erik

Agent Pizzeys

Pub. Number AU-A-2004291102

PCT Pub. Number WO2005/049084

Priority 60/519,980 13.11.03 US

Filing date 12 November 2004

Wipo publication date 2 June 2005

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/049084 Priority application(s): WO2005/049084

16 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004291104-Infusion set

2004291101-Oxime substituted imidazo ring compounds